PDCD1 and neoplasm: The TREX1-targeting small molecule CPI-38 from Constellation (Table 6E) demonstrates decreased tumor growth in the MC38 (colorectal carcinoma) syngeneic tumor model, both as a standalone treatment and when combined with anti-PD-1 (172).